Insulin aspart injection

Fiasp is a fast-acting insulin aspart injection used to control blood sugar levels in people with diabetes. Manufactured by Novo Nordisk, it's available as a subcutaneous solution in pens and cartridges, with strengths like 100 units/mL. It helps manage hyperglycemia when used with diet and exercise. This information was generated using AI and is provided for informational and research purposes only.